The impact of type 2 diabetes and obesity on the long‐term outcomes of more than 85 000 liver transplant recipients in the US
Authors:
Open Access
- 16 July 2014
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 40 (6) , 686-694
Abstract
Summary: Background: Type 2 diabetes is known to negatively impact the outcome of chronic liver disease.Aim: To evaluate the impact of diabetes on the outcomes of liver transplants (LT).Methods: Study cohort included adults (>18 years) who received LT in the US between 1994 and 2013 (The Scientific Registry of Transplant Recipients). Pre‐ and post‐transplant diabetes was recorded in patients with mortality follow‐up.Results: We included 85 194 liver transplant recipients. Of those, 11.2% had history of pre‐transplant diabetes. The most common indications for liver transplant were hepatitis C (36.4%), alcohol‐related liver disease (20.6%), primary liver malignancy of unspecified aetiology (14.7%), cryptogenic cirrhosis (8.0%), hepatitis B (4.6%) and non‐alcoholic steatohepatitis (3.9%). A total of 96.5% transplants were from deceased donors, and 7.9% donors had history of diabetes. During an average 6.5 years of follow‐up, 31.3% recipients died and 8.8% had a graft failure. In multivariate survival analysis [at least 5 years of cohort follow‐up (N = 35 870)], after adjustment for age, ethnicity, insurance type, history of chronic diseases, HCV infection and noncompliance, independent predictors of recipient mortality included the presence of pre‐transplant diabetes [adjusted hazard ratio (95%CI) = 1.21 (1.12–1.30)] and developing diabetes post‐transplant [1.06 (1.02–1.11)]. Donor's history of diabetes was also independently associated with higher mortality [1.10 (1.02–1.19)]. Furthermore, donor's history of diabetes was also associated with an increased the risk of liver graft failure [1.35 (1.24–1.47)].Conclusions: Presence of type 2 diabetes pre‐ and post‐transplant, as well as presence of type 2 diabetes in the donors, are all associated with an increased risk of adverse post‐transplant outcomes.Keywords
This publication has 32 references indexed in Scilit:
- The Evolution of Liver Transplantation During 3 DecadesAnnals of Surgery, 2013
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008Clinical Gastroenterology and Hepatology, 2011
- Adult liver transplantation in the USACurrent Opinion in Gastroenterology, 2011
- Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based studyGut, 2010
- Diabetes Mellitus Increases the Risk of Mortality Following Liver Transplantation Independent of MELD ScoreDigestive Diseases and Sciences, 2010
- Model for End-Stage Liver Disease (MELD) Score System to Evaluate Patients With Viral Hepatitis on the Waiting List: Better Than the Child-Turcotte-Pugh (CTP) System?Transplantation Proceedings, 2008
- Donor Characteristics Associated with Liver Graft SurvivalTransplantation, 2005
- Patient selection in an era of donor liver shortage: current US policyNature Clinical Practice Gastroenterology & Hepatology, 2005
- Model for end-stage liver disease (MELD) and allocation of donor liversGastroenterology, 2003
- USE OF FATTY DONOR LIVER IS ASSOCIATED WITH DIMINISHED EARLY PATIENT AND GRAFT SURVIVALTransplantation, 1996